United Kingdom· GB-APID-19823011000001108
Bufyl 1.25mg/ml and 2micrograms/ml 250ml infusion bags
A medicinal product containing bupivacaine + fentanyl, registered in United Kingdom by Sandoz Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bupivacaine + Fentanyl
- Manufacturer
- Sandoz Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5099602001732
- gtin05021691001522
- gtin04260012944921
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bupivacaine + fentanyl in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0ba39fa-7e07-4a8f-874e-bb5a6e36459f GET /v1/drugs/c0ba39fa-7e07-4a8f-874e-bb5a6e36459f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "19823011000001108",
"desc": "Bufyl 1.25mg/ml and 2micrograms/ml 250ml infusion bags (Sandoz Ltd)",
"form": "Infusion",
"vpid": "19822911000001100",
"source": "dmd",
"vtm_id": "17066911000001103",
"strength": "2 microgram",
"substance": "Bupivacaine + Fentanyl",
"ingredient": "Fentanyl citrate",
"supplier_code": "2074301000001102"
}See everything about bupivacaine + fentanyl.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.